27.12.2012 Views

12th Congress of the European Hematology ... - Haematologica

12th Congress of the European Hematology ... - Haematologica

12th Congress of the European Hematology ... - Haematologica

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

acquire a cytolytic capacity against leukemia cell lines and against allogeneic<br />

primary AML blasts. Summary and conclusions. These results confirm<br />

that NK cells can be significantly expanded under GMP conditions<br />

and indicate that from 100 mL <strong>of</strong> donor peripheral blood it is possible<br />

to obtain 1-5×10 8 NK cells, which means <strong>the</strong> opportunity <strong>of</strong> infusing<br />

into a recipient <strong>of</strong> 70 kg 1.5-7×10 8 NK cells/kg <strong>of</strong> body weight. Taken<br />

toge<strong>the</strong>r, <strong>the</strong>se findings indicate a possible new strategy for <strong>the</strong> expansion<br />

<strong>of</strong> cytolytic effectors that may be considered for <strong>the</strong> management<br />

<strong>of</strong> AML patients with evidence <strong>of</strong> disease persistence or recurrence after<br />

an allogeneic SCT. Clinical protocols appear feasible, particularly considering<br />

that <strong>the</strong> infusion <strong>of</strong> NK cells should induce very limited toxicity and<br />

no or very low risk <strong>of</strong> graft-versus-host disease, thus avoiding <strong>the</strong> potential<br />

complications associated to donor T-lymphocyte infusions.<br />

0594<br />

PLASMA CHANGES OF ENDOTHELIAL INJURY MARKERS IN PATIENTS TREATED WITH<br />

DIFFERENT CONDITIONING REGIMENS FOLLOWED BY HAEMATOPOIETIC STEM CELL<br />

TRANSPLANTATION<br />

A. Czyz, A. Blazejczak, A. Lojko, E. Hanszke, L. Gil, D. Dytfeld,<br />

K. Zawilska, M. Komarnicki<br />

University <strong>of</strong> Medical Sciences, POZNAN, Poland<br />

Background. The endo<strong>the</strong>lial injury caused by conditioning regimen is<br />

thought to play a central role in <strong>the</strong> non-infectious complications in<br />

patients undergoing haematopoietic stem cell transplantation. The aim<br />

<strong>of</strong> <strong>the</strong> study was to evaluate <strong>the</strong> plasma changes <strong>of</strong> endo<strong>the</strong>lial injury<br />

markers in patients treated with different type <strong>of</strong> preparative regimens<br />

and to investigate whe<strong>the</strong>r <strong>the</strong>se changes are associated with toxicity <strong>of</strong><br />

conditioning schedule. Patients and Methods. Plasma levels <strong>of</strong> von Willebrand<br />

factor antigen (vWF Ag), trombomodulin (TM) and vascular<br />

endo<strong>the</strong>lial growth factor (VEGF) were measured by immunoassay tests<br />

in 21 patients (pts), median age 30 (19-67) years, transplanted with allogeneic<br />

(18 pts) or autologous (3 pts) haematopoietic stem cells after<br />

BuCy2 (busulfan 16 mg/kg, cyclophosphamide 120 mg/kg) - 5 pts,<br />

TBI/Cy (total body irradiation 12 Gy, cyclophosphamide 120 mg/kg)- 5<br />

pts, Treo/Cy (treosulfan 14 mg/m2 , cyclophosphamide 120 mg/kg)- 6<br />

pts or fludarabine-based reduced-intensity regimen- 4 pts for AML (10<br />

pts), ALL (5 pts), CML (4 pts) and AA (1 patient). For <strong>the</strong> statistical analysis<br />

patients were divided into <strong>the</strong> subgroups according to <strong>the</strong> type <strong>of</strong> conditioning<br />

schedule: 1.BuCy2 2.TBI/Cy 3.myeloablative regimens<br />

(BuCy2, TBI/CY) and 4.reduced-toxicity regimens (fludarabine-based<br />

regimen, Treo/CY). Endo<strong>the</strong>lial injury markers were measured before<br />

conditioning regimen (day -10), and on <strong>the</strong> day <strong>of</strong> stem cells infusion, 48<br />

hours after finishing preparative schedule, but before stem cells infusion<br />

(day 0). Results. After conditioning regimen vWF Ag concentration<br />

increased significantly on <strong>the</strong> day 0 in comparison to <strong>the</strong> day -10 (p<<br />

0.05) in <strong>the</strong> whole study group. wWF Ag concentration did not differ significantly<br />

between subgroups on <strong>the</strong> day 0. In <strong>the</strong> subgroup treated with<br />

TBI based regimen (5 pts) VEGF level increased on <strong>the</strong> day 0 in comparison<br />

to <strong>the</strong> day -10 (p

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!